Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
Open Access
- 14 January 2009
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 7 (1), 2
- https://doi.org/10.1186/1741-7015-7-2
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Inhaled Corticosteroids in Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2007
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- Chronic Obstructive Pulmonary Disease: A Growing but Neglected Global EpidemicPLoS Medicine, 2007
- A Decision Aid for COPD patients considering inhaled steroid therapy: development and before and after pilot testingBMC Medical Informatics and Decision Making, 2007
- Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trialClinical Therapeutics, 2007
- The effect of tiotropium on exacerbations and airflow in patients with COPDEuropean Respiratory Journal, 2006
- Addition of salmeterol to existing treatment in patients with COPD: a 12 month studyThorax, 2006
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly headStatistics in Medicine, 2002